Nurhan Cucer

Nurhan Cucer

Auto-generated profile, based on publicly available information

Nurhan Cucer

Department of Medical Biology, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Micron
Verified
Journal Article
Closed access
NCNurhan Cucer
Nurhan Cucer
NINalan Imamoglu
Nalan Imamoglu
HALIME TOZAK YILDIZHALIME TOZAK YILDIZ
HALIME TOZAK YILDIZ
HDHalil Demirtas
Halil Demirtas
FSFulya Sarac
Fulya Sarac
FÖFigen Öztürk
Figen Öztürk

1 November 2025 in MicroRNA
Verified
Journal Article
Closed access
PDF file
RÜRamazan Üzen
Ramazan Üzen
FBFahri Bayram
Fahri Bayram
HDHuseyin Dursun
Huseyin Dursun
FKFatih Kardas
Fatih Kardas
MÇMustafa Çakır
Mustafa Çakır
HAHamiyet Donmez Altuntas
Hamiyet Donmez Altuntas
Background: Gaucher disease (GD) occurs due to a mutation in the glucosylcerami-dase (GBA) gene and is a common lysosomal storage disease. It is well known that there is a strong association between the abnormal expression of miRNAs and various diseases including cancer. These abnormally expressed miRNAs can be used as biomarkers. Interestingly, several studies have reported a linkage between GD with an increased risk of cancer. Therefore, in the current study, we investigated the expression levels of selected miRNAs that are associated with cancers that might have potential use as biomarkers in GD. Methods: Blood samples were collected from 24 healthy volunteers, 6 carriers, and 20 treated patients with type 1 GD. A reverse transcription-quantitative real-time PCR (RT-qPCR) platform was used to analyze the miRNA expression levels. Results: While carriers had lower relative expressions of miRNA-15a with tumor suppressor ef-fect, and miRNA-150 and miRNA-181b with oncogene effect, treated patients with type 1 GD had lower relative expressions of miRNA-15a and miRNA-125b with tumor suppressor effect and higher relative expression miRNA-21 with oncogene effect (p<0.001, p<0.05, p<0.01, p<0.05, p<0.001, and p<0.05, respectively). Conclusion: The results suggested that the downregulation of miRNA-15a and miRNA-125b expressions with tumor suppressor effect and the upregulation of miRNA-21 expression with on-cogene effect can be indicated to an increased risk for cancers such as multiple myeloma (MM), B-cell lymphoma, leukemia, and hepatocellular carcinoma (HCC) in GD.